From: Sebastian-A Molineus [mailto:smolineus@worldbank.org]
Sent: 26 March, 2021 17:44
To: Ekaterine Tikaradze
Cc: Tania Dmytraczenko
Subject: RE: Weekly Vaccine Marketplace Update as of 26 March, 2021 - with attachment
Dear colleagues – once again, this week’s Vaccine Marketplace Update as of March 26. Key highlights:
1. The EU’s export controls for vaccines: The European Union moved toward stricter export controls for coronavirus vaccines. Notably, the mechanism does not apply to Covax or Canada. Although the commission says no country is targeted by the mechanism, it is no secret that the biggest point of friction is with AstraZeneca, based in Britain. In counter arguments, Pfizer has warned that imposing export controls could lead to retaliation from the UK which is where Pfizer sources raw materials for its vaccines.
2. Tech Firms are getting ready to set standards for vaccine verification: A coalition that includes tech giants and healthcare providers is preparing to release global standards for mobile apps that verify whether someone has had a Covid-19 vaccine. The Vaccination Credential Initiative standards will incorporate digitally-verified clinical data with a name and birth date that can be also displayed as machine-readable QR codes. After the open-source standards are released next month, they can be integrated into mobile apps that people could use to verify they have been vaccinated to gain admission to offices, restaurants, bars, entertainment venues and other public places.
3. Hungary approves CanSino vaccine: Hungary approved Convidecia, the single dose vaccine developed by CanSino. This is the second Chinese-produced vaccine approved in Hungary after the Sinopharm vaccine was approved in February. The CanSino vaccine is currently approved for use in China, Pakistan and Mexico
In terms of vaccinations, more than 486 million doses (Last week: 400 million) have been administered across 137 countries (Last week: 132 countries), according to data collected by Bloomberg. The latest rate was roughly 11.9million doses a day (Last week: 9.64 million doses a day).
Thank you and kind regards,
Sebastian
Sebastian Molineus
Regional Director for the South Caucasus
Europe and Central Asia
T +995 (32) 291 6238
M +995 (577) 78 7821
M +1 (202) 492-3914
E smolineus@worldbank.org
W www.worldbank.org/en/region/eca
@smolineus
| |
_____________________________________________
From: Sebastian-A Molineus
Sent: Friday, March 19, 2021 2:03 PM
To: Ekaterine Tikaradze <etikaradze@moh.gov.ge>; Tamar Gabunia <tgabunia@moh.gov.ge>; Ivane Matchavariani (i.matchavariani@mof.ge) <i.matchavariani@mof.ge>; giorgi.kakauridze@mof.ge; 'n.gagua@mof.ge' <n.gagua@mof.ge>; Alexander Khvtisiashvili <a.khvtisiashvili@mfa.gov.ge>
Cc: Tania Dmytraczenko <tdmytraczenko@worldbank.org>; Ahmet Levent Yener <alyener@worldbank.org>; Volkan Cetinkaya <vcetinkaya@worldbank.org>; Nino V. Moroshkina <nmoroshkina@worldbank.org>
Subject: RE: Weekly Vaccine Marketplace Update as of 18 March, 2021 - with attachment
<< File: Vaccine Marketplace Update - as at 03-18-21.pptx >>
Dear colleagues -
Please find attached the weekly vaccine marketplace update as of 18 March. Some highlights:
1. AstraZeneca and the EU: Germany, France, Italy and Spain said they would resume using the Oxford/AstraZeneca coronavirus vaccine after the EU drugs regulator EMA and the WHO said there was a “clear scientific conclusion” that the jab was “safe and effective”. This was after 13 EU countries suspended use of the vaccine amid concerns over blood clots.
2. Vaccine diplomacy: The United States, India, Australia and Japan have pledged to deliver a billion doses of Covid-19 vaccine throughout the Indo-Pacific by the end of 2022 in what is widely seen as a bid to counter China's influence in the region. While in separate move, China is donating 300,000 doses of COVID-19 vaccines to U.N. peacekeepers, with priority given to those serving in Africa.
3. Johnson & Johnson gets two major approvals: The European Commission granted a conditional marketing authorization after the EU’s drugs regulator recommended approval for all adults earlier Thursday. It’s the fourth shot to be cleared in the region. Shortly thereafter, the World Health Organization granted an emergency use listing for the coronavirus vaccine made by Johnson & Johnson, meaning the one-dose shot can now theoretically be used as part of the international COVAX effort.
In terms of vaccinations, more than 400 million doses (Last week: 330 million) have been administered across 132 countries (Last week: 121 countries), according to data collected by Bloomberg. The latest rate was roughly 9.64 million doses a day (Last week: 8.47 million doses a day).
Thank you and kind regards,
Sebastian
Sebastian Molineus
Regional Director for the South CaucasusEurope and Central Asia
T +995 (32) 291 6238
M +995 (577) 78 7821
M +1 (202) 492-3914
E smolineus@worldbank.org
W www.worldbank.org/en/region/eca
@smolineus
| |
_____________________________________________
From: Sebastian-A Molineus
Sent: Friday, March 12, 2021 8:15 AM
To: Ekaterine Tikaradze <etikaradze@moh.gov.ge>; Tamar Gabunia <tgabunia@moh.gov.ge>; Ivane Matchavariani (i.matchavariani@mof.ge) <i.matchavariani@mof.ge>
Cc: Tania Dmytraczenko <tdmytraczenko@worldbank.org>; Ahmet Levent Yener <alyener@worldbank.org>; Volkan Cetinkaya <vcetinkaya@worldbank.org>; Nino V. Moroshkina <nmoroshkina@worldbank.org>
Subject: RE: Weekly Vaccine Marketplace Update as of 11 March, 2021 - with attachment
Dear Tamar – it was a pleasure meeting last night to help answer some of your questions on vaccine purchasing strategy. As discussed, we are putting you in touch with the authorities in Ukraine (for their experience with Crown), as well as the UAE (re. Sinopharm), and Armenia (to discuss possibly pooling, e.g. with respect to NOVOVAX, where I’d like to again highlight our advice to strike early, fast, and at great bulk!). On NOVOVAX, please note that they just released their updated results last night (see https://ir.novavax.com/node/15656/pdf), and they are: 96.4% effective against mild disease; 100% effective against hospitalizations; and 100% effective against death. Again, you may wish to move quickly on this and purchase larger quantities given the first mover advantage we discussed last night!
And attached is this week’s vaccine marketplace update – shared with you on a confidential basis. Of note is that Italy approved the AstraZeneca vaccine for over-65s, following a number of other European nations reversing their previous decisions to not use the vaccine for people over-65, including France and Germany.
<< File: Vaccine Marketplace Update - as at 03-11-21.pptx >>
Thank you and kind regards,
Sebastian
Sebastian Molineus
Regional Director for the South CaucasusEurope and Central Asia
T +995 (32) 291 6238
M +995 (577) 78 7821
M +1 (202) 492-3914
E smolineus@worldbank.org
W www.worldbank.org/en/region/eca
@smolineus
| |
_____________________________________________
From: Sebastian-A Molineus
Sent: Sunday, March 7, 2021 2:27 PM
To: Ivane Matchavariani (i.matchavariani@mof.ge) <i.matchavariani@mof.ge>; Ekaterine Tikaradze <etikaradze@moh.gov.ge>; Tamar Gabunia <tgabunia@moh.gov.ge>
Cc: Tania Dmytraczenko <tdmytraczenko@worldbank.org>; Ahmet Levent Yener <alyener@worldbank.org>; Volkan Cetinkaya <vcetinkaya@worldbank.org>; Nino V. Moroshkina <nmoroshkina@worldbank.org>
Subject: Weekly Vaccine Marketplace Update as of 4 March, 2021 - with attachment
<< File: Vaccine Marketplace Update - as at 03-04-21.pptx >>
Dear Ivane, Eka, and Tamar -
please find attached the weekly vaccine marketplace update. A few highlights:
1. Johnson and Johnson was approved by the FDA. This is the first single dose vaccine to be approved by an SRA. It is considered a game changer within the USA because it is the first non-mRNA vaccine which means it can be stored and transported at normal freezer temperatures.
2. COVAX is starting to gain steam. Ghana, Ivory Coast, South Korea, India and Colombia have already received their first deliveries of vaccines through Covax. Nigeria, Angola, Cambodia all received their first vaccine doses via Covax this week, with the DR Congo also scheduled for a delivery. And this of course now also includes Georgia!
3. The EU is considering switching to Emergency Use approvals. Under pressure to speed up its approval process, The European Commission said that it was considering emergency approvals for COVID-19 vaccines as a faster alternative to more rigorous conditional marketing authorizations which have been used so far.
In terms of Vaccinations; more than 271 million doses (Last week: 218 million) have been administered across 108 countries (Last week: 99 countries), according to data collected by Bloomberg. The latest rate was roughly 6.36 million doses a day (Last week: 6.14 million doses a day).
As always, I would ask that you pls. keep this information confidential.
Thank you and kind regards,
Sebastian
Sebastian Molineus
Regional Director for the South CaucasusEurope and Central Asia
T +995 (32) 291 6238
M +995 (577) 78 7821
M +1 (202) 492-3914
E smolineus@worldbank.org
W www.worldbank.org/en/region/eca
@smolineus
| |